UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer

Clinical cancer research, 2015-04, Vol.21 (7), p.1688-1698

2015

Volltextzugriff (PDF)

Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8

Cancer research (Chicago, Ill.), 2013-06, Vol.73 (11), p.3470-3480

2013

Volltextzugriff (PDF)

EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells

Nature communications, 2017-06, Vol.8 (1), p.15773-15773, Article 15773

2017

Volltextzugriff (PDF)

An epigenomic approach to therapy for tamoxifen-resistant breast cancer

Cell research, 2014-07, Vol.24 (7), p.809-819

2014

Volltextzugriff (PDF)

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: TBCRC 006

Journal of clinical oncology, 2013-05, Vol.31 (14), p.1726-1731

2013

Volltextzugriff (PDF)

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

Cancer research (Chicago, Ill.), 2013-08, Vol.73 (15), p.4885-4897

2013

Volltextzugriff (PDF)

Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

Cancer research (Chicago, Ill.), 2010-11, Vol.70 (21), p.8517-8525

2010

Volltextzugriff (PDF)

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Journal of clinical oncology, 2011-01, Vol.29 (2), p.166-173

2011

Volltextzugriff (PDF)

Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival

Cancer research (Chicago, Ill.), 2016-04, Vol.76 (7), p.1942-1953

2016

Volltextzugriff (PDF)

Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis

Journal of clinical oncology, 2008-09, Vol.26 (25), p.4078-4085

2008

Volltextzugriff (PDF)

Modernizing Eligibility Criteria for Molecularly Driven Trials

Journal of clinical oncology, 2015-09, Vol.33 (25), p.2815-2820

2015

Volltextzugriff (PDF)

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast cancer research : BCR, 2024-02, Vol.26 (1), p.23-23, Article 23

2024

Volltextzugriff (PDF)

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Breast cancer research : BCR, 2024-03, Vol.26 (1), p.53-53, Article 53

2024

Volltextzugriff (PDF)

Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

Breast cancer research : BCR, 2010-06, Vol.12 (3), p.R40-R40, Article R40

2010

Volltextzugriff (PDF)

The Signaling Pathways Project, an integrated 'omics knowledgebase for mammalian cellular signaling pathways

Scientific data, 2019-10, Vol.6 (1), p.252-21, Article 252

2019

Volltextzugriff (PDF)

CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT

Nature communications, 2016-11, Vol.7 (1), p.13362-15, Article 13362

2016

Volltextzugriff (PDF)

Assessment of the learning curve for pancreaticoduodenectomy

The American journal of surgery, 2012-06, Vol.203 (6), p.684-690

2012

Volltextzugriff (PDF)

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression

Oncotarget, 2016-03, Vol.7 (11), p.13106-13121

2016

Volltextzugriff (PDF)

Making Sense of Clinical Trial Data: Is Inverse Probability of Censoring Weighted Analysis the Answer to Crossover Bias?

Journal of clinical oncology, 2012-02, Vol.30 (4), p.453-458

2012

Volltextzugriff (PDF)

Social Networkers' Attitudes Toward Direct-to-Consumer Personal Genome Testing

American journal of bioethics, 2009-01, Vol.9 (6-7), p.3-10

2009

Volltextzugriff (PDF)

HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes

Cancer research (Chicago, Ill.), 2016-03, Vol.76 (6), p.1463-1475

2016

Volltextzugriff (PDF)

Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials

Clinical cancer research, 2016-09, Vol.22 (17), p.4291-4301

2016

Volltextzugriff (PDF)

The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer

Journal of clinical oncology, 2006-10, Vol.24 (28), p.4611-4619

2006

Volltextzugriff (PDF)

Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation

Cell reports (Cambridge), 2015-07, Vol.12 (3), p.511-524

2015

Volltextzugriff (PDF)

1 – 25 von 348

Suche als RSS-Feed

Aktive Filter

KollektionJSTOR Complete Journals

KollektionWiley Blackwell Single Titles

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(341)
Mit Volltextzugriff
(321)

Publikationsform

Artikel
(347)
Tagungsberichte
(1)

Sprache

Englisch
(348)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Comprehensive genomic analysis identifies novel subtypes and targets of triple-negative breast cancer

Growth of Triple-Negative Breast Cancer Cells Relies upon Coordinate Autocrine Expression of the Proinflammatory Cytokines IL-6 and IL-8

EMT cells increase breast cancer metastasis via paracrine GLI activation in neighbouring tumour cells

An epigenomic approach to therapy for tamoxifen-resistant breast cancer

Multicenter Phase II Study of Neoadjuvant Lapatinib and Trastuzumab With Hormonal Therapy and Without Chemotherapy in Patients With Human Epidermal Growth Factor Receptor 2–Overexpressing Breast Cancer: TBCRC 006

A Renewable Tissue Resource of Phenotypically Stable, Biologically and Ethnically Diverse, Patient-Derived Human Breast Cancer Xenograft Models

Hippo Pathway Effector Yap Is an Ovarian Cancer Oncogene

Loss of Phosphatase and Tensin Homolog or Phosphoinositol-3 Kinase Activation and Response to Trastuzumab or Lapatinib in Human Epidermal Growth Factor Receptor 2–Overexpressing Locally Advanced Breast Cancers

Phosphatase PTP4A3 Promotes Triple-Negative Breast Cancer Growth and Predicts Poor Patient Survival

Insulin-Like Growth Factor-I Activates Gene Transcription Programs Strongly Associated With Poor Breast Cancer Prognosis

Modernizing Eligibility Criteria for Molecularly Driven Trials

The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Activation of Multiple Proto-oncogenic Tyrosine Kinases in Breast Cancer via Loss of the PTPN12 Phosphatase

Correction: The novel phosphatase NUDT5 is a critical regulator of triple-negative breast cancer growth

Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer

The Signaling Pathways Project, an integrated 'omics knowledgebase for mammalian cellular signaling pathways

CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT

Assessment of the learning curve for pancreaticoduodenectomy

The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expression

Making Sense of Clinical Trial Data: Is Inverse Probability of Censoring Weighted Analysis the Answer to Crossover Bias?

Social Networkers' Attitudes Toward Direct-to-Consumer Personal Genome Testing

HER2 Signaling Drives DNA Anabolism and Proliferation through SRC-3 Phosphorylation and E2F1-Regulated Genes

Bayesian Optimal Interval Design: A Simple and Well-Performing Design for Phase I Oncology Trials

The HOXB13:IL17BR Expression Index Is a Prognostic Factor in Early-Stage Breast Cancer

Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation

Aktive Filter

Suchergebnisse filtern